Zenity Enhances Security from Buildtime to Runtime for Enterprise AI Agents with Copilot Studio

Zenity and Microsoft Copilot Studio deliver end-to-end security to help enterprises scale AI Agent adoption with visibility, control, and real-time threat protection. Zenity, a leading end-to-end security and governance platform for AI Agents, today announced an enhancement to integration with Microsoft Copilot Studio, to provide enterprises with continuous visibility, vulnerability assessment, and threat detection to

Benchmark Initiates Research Coverage of TNL Mediagene

TNLMediagene (Nasdaq: TNMG) (the “Company”), a Tokyo-based next-generation digital media and data group in Asia, today announced that The Benchmark Company, LLC (“Benchmark”) has initiated research coverage of the Company. For details regarding Benchmark’s research report, please contact Benchmarkdirectly. The independent research report, prepared by and solely reflecting the views of The Benchmark Company, LLC,

Learn How AI and AR Are Transforming Fashion at Hartmann Capital’s Upcoming Frontier Forum with DRESSX

Webinar brings together investors, founders, and futurists to unpack the next wave of digital fashion, AI, and virtual identity As the lines between physical and digital fashion continue to blur, Hartmann Capital and DRESSX are set to host a timely webinar exploring the rise of wearable augmented reality, digital identity, and the future of AI-powered

EdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CRO

Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical trials. Comac Medical Group (“Group”), based in the UK and backed by EdgeCap Partners, announced today the acquisition of ILIFE Consulting (“ILIFE”), a specialized Contract Research Organization (CRO) headquartered in Paris, France, renowned for its expertise in

SINEXCEL and Phoenix Contact Sign Global Strategic Partnership Agreement

SINEXCEL(300693.SZ) has officially signed a global strategic partnership agreement with Phoenix Contact at the PHIIDF (Phoenix Contact Innovation and Industry Development Forum) in Shenzhen. https://mma.prnewswire.com/media/2694107/SINEXCEL.jpg Under this agreement, SINEXCEL and Phoenix Contact will collaborate extensively in the electric vehicle (EV) sector, leveraging each company’s expertise to drive innovation. SINEXCEL’s advanced power electronics and cutting-edge EV

Levi & Korsinsky Investigates Possible Securities Fraud by Myriad Genetics, Inc. (MYGN)

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Myriad Genetics, Inc. ("Myriad Genetics, Inc.") (NASDAQ:MYGN) concerning possible violations of federal securities laws. Myriad released its first quarter 2025 financial results on May 6, 2025, revealing "revenue of $196 million declined

Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025 Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149597&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025 Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149597&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Filed Against Ibotta, Inc. (IBTA) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=149596&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top